From: Modulating effect of the PI3-kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells
 | Control | Cisplatin (5 mg/kg) | LY294002 (25 mg/kg) | Cisplatin (5 mg/kg) + LY294002 (25 mg/kg) |
---|---|---|---|---|
Body weight (g) | 23.7 ± 0.8 | 23.6 ± 0.5 | 23.8 ± 0.7 | 23.7 ± 0.8 |
Serum albumin (g/dl) | 3.2 ± 0.2 | 3.1 ± 0.2 | 3.1 ± 0.3 | 3.2 ± 0.2 |
Total bilirubin (mg/dl) | 0.04 ± 0.02 | 0.05 ± 0.01 | 0.06 ± 0.01 | 0.04 ± 0.02 |
Creatinine (mg/dl) | 0.05 ± 0.02 | 0.06 ± 0.02 | 0.08 ± 0.02 | 0.05 ± 0.03 |
ALT (IU/l) | 34.1 ± 9.7 | 31.5 ± 5.6 | 30.0 ± 6.7 | 44.1 ± 9.7 * |